Objective
To ascertain Australian obstetric sonographers knowledge and current practice when assessing for vasa praevia in the mid‐trimester ultrasound with the view to improve prenatal diagnosis.
Methods
Between August and September 2018, a survey was emailed to 4868 Australian sonographers registered to participate in Australian Sonography Association Registry (ASAR) facilitated research projects. A total of 577 responses were received. The sonographers survey response was compared with published Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) recommendations.
Results
There appears to be an unfamiliarity with the RANZCOG recommendations, in particular that vasa praevia is defined as a fetal vessel lying within 20 mm of the cervical internal os (IOS). Transabdominally, if a vasa praevia risk factor is identified (including a fetal vessel observed in the lower uterine segment), less than 48% of surveyed sonographers proceed to a targeted transvaginal scan.
Conclusion
To enable effective diagnosis of vasa praevia, it is important to recognise associated risk factors that can raise suspicion for a potential vasa praevia; these are velamentous cord insertion, succenturiate lobe, and low‐lying placenta. A lower threshold of performing a transvaginal ultrasound when risk factors are identified (including a fetal vessel is identified in the lower uterine segment) may significantly improve vasa praevia diagnosis in the mid‐trimester ultrasound.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.